Shelanski M - Search Results

1

A systems approach to drug discovery in Alzheimer's disease.

Shelanski M, Shin W, Aubry S, Sims P, Alvarez MJ, Califano A. Shelanski M, et al. Neurotherapeutics. 2015 Jan;12(1):126-31. doi: 10.1007/s13311-014-0335-5. Neurotherapeutics. 2015. PMID: 25608936 Free PMC article. Review.

2

Assembly and interrogation of Alzheimer's disease genetic networks reveal novel regulators of progression.

Aubry S, Shin W, Crary JF, Lefort R, Qureshi YH, Lefebvre C, Califano A, Shelanski ML. Aubry S, et al. PLoS One. 2015 Mar 17;10(3):e0120352. doi: 10.1371/journal.pone.0120352. eCollection 2015. PLoS One. 2015. PMID: 25781952 Free PMC article.

3

Stuck in the mire.

Shelanski M, Lefort R. Shelanski M, et al. Neurotherapeutics. 2015 Jan;12(1):1-2. doi: 10.1007/s13311-014-0333-7. Neurotherapeutics. 2015. PMID: 25608935 Free PMC article. No abstract available.

4

Reversal of long-term dendritic spine alterations in Alzheimer disease models.

Smith DL, Pozueta J, Gong B, Arancio O, Shelanski M. Smith DL, et al. Among authors: shelanski m. Proc Natl Acad Sci U S A. 2009 Sep 29;106(39):16877-82. doi: 10.1073/pnas.0908706106. Epub 2009 Sep 14. Proc Natl Acad Sci U S A. 2009. PMID: 19805389 Free PMC article.

5

Isolation and characterization of amyloid P component from Alzheimer's disease and other types of cerebral amyloidosis.

Coria F, Castaño E, Prelli F, Larrondo-Lillo M, van Duinen S, Shelanski ML, Frangione B. Coria F, et al. Among authors: shelanski ml. Lab Invest. 1988 Apr;58(4):454-8. Lab Invest. 1988. PMID: 2965774

6

Dendrite and dendritic spine alterations in Alzheimer models.

Moolman DL, Vitolo OV, Vonsattel JP, Shelanski ML. Moolman DL, et al. J Neurocytol. 2004 May;33(3):377-87. doi: 10.1023/B:NEUR.0000044197.83514.64. J Neurocytol. 2004. PMID: 15475691

7

Synergistic effects of traumatic head injury and apolipoprotein-epsilon 4 in patients with Alzheimer's disease.

Mayeux R, Ottman R, Maestre G, Ngai C, Tang MX, Ginsberg H, Chun M, Tycko B, Shelanski M. Mayeux R, et al. Among authors: shelanski m. Neurology. 1995 Mar;45(3 Pt 1):555-7. doi: 10.1212/wnl.45.3.555. Neurology. 1995. PMID: 7898715

8

Beta-protein deposition: a pathogenetic link between Alzheimer's disease and cerebral amyloid angiopathies.

Coria F, Prelli F, Castaño EM, Larrondo-Lillo M, Fernandez-Gonzalez J, van Duinen SG, Bots GT, Luyendijk W, Shelanski ML, Frangione B. Coria F, et al. Among authors: shelanski ml. Brain Res. 1988 Oct 25;463(1):187-91. doi: 10.1016/0006-8993(88)90545-8. Brain Res. 1988. PMID: 3058268 Free article.

9

Post-translational remodeling of ryanodine receptor induces calcium leak leading to Alzheimer's disease-like pathologies and cognitive deficits.

Lacampagne A, Liu X, Reiken S, Bussiere R, Meli AC, Lauritzen I, Teich AF, Zalk R, Saint N, Arancio O, Bauer C, Duprat F, Briggs CA, Chakroborty S, Stutzmann GE, Shelanski ML, Checler F, Chami M, Marks AR. Lacampagne A, et al. Among authors: shelanski ml. Acta Neuropathol. 2017 Nov;134(5):749-767. doi: 10.1007/s00401-017-1733-7. Epub 2017 Jun 19. Acta Neuropathol. 2017. PMID: 28631094 Free article.

10

Cross-linking of cell surface amyloid precursor protein leads to increased β-amyloid peptide production in hippocampal neurons: implications for Alzheimer's disease.

Lefort R, Pozueta J, Shelanski M. Lefort R, et al. Among authors: shelanski m. J Neurosci. 2012 Aug 1;32(31):10674-85. doi: 10.1523/JNEUROSCI.6473-11.2012. J Neurosci. 2012. PMID: 22855816 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

191 results

Search Page

Filters